Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 28, 2021
THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial
Jean-Christophe Corvol, Jean-Philippe Azulay, Björn Bosse, et al.
Molecules (Basel, Switzerland)
|
November 15, 2018
Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon
Reuel L de Paula, Joyce S F D de Almeida, Samir F A Cavalcante, et al.
BMC Pharmacology & Toxicology
|
February 23, 2018
A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase
Kamil Kuca, Kamil Musilek, Daniel Jun, et al.
Journal of Biomolecular Structure & Dynamics
|
February 23, 2023
Anastrozole-mediated modulation of mitochondrial activity by inhibition of mitochondrial permeability transition pore opening: an initial perspective
Somesh Kumar, Neha Choudhary, Mohammed Faruq, et al.
Multiple Sclerosis and Related Disorders
|
June 22, 2023
Is breastfeeding in MS harmful or not? An answer from real-world Czech data
Pavel Hradilek, Olga Zapletalova, Petra Hanulikova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 27, 2025
Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial
Peter A Calabresi, Gavin Giovannoni, Hans-Peter Hartung, et al.
Bioorganic Chemistry
|
January 9, 2021
Tacrine - Benzothiazoles: Novel class of potential multitarget anti-Alzheimeŕs drugs dealing with cholinergic, amyloid and mitochondrial systems
Eugenie Nepovimova, Lucie Svobodova, Rafael Dolezal, et al.
European Journal of Medicinal Chemistry
|
March 10, 2019
Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease
Katarina Chalupova, Jan Korabecny, Manuela Bartolini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 4, 2021
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study
Amit Bar-Or, Heinz Wiendl, Xavier Montalban, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 28, 2021
THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial
Jean-Christophe Corvol, Jean-Philippe Azulay, Björn Bosse, et al.
Molecules (Basel, Switzerland)
|
November 15, 2018
Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon
Reuel L de Paula, Joyce S F D de Almeida, Samir F A Cavalcante, et al.
BMC Pharmacology & Toxicology
|
February 23, 2018
A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase
Kamil Kuca, Kamil Musilek, Daniel Jun, et al.
Journal of Biomolecular Structure & Dynamics
|
February 23, 2023
Anastrozole-mediated modulation of mitochondrial activity by inhibition of mitochondrial permeability transition pore opening: an initial perspective
Somesh Kumar, Neha Choudhary, Mohammed Faruq, et al.
Multiple Sclerosis and Related Disorders
|
June 22, 2023
Is breastfeeding in MS harmful or not? An answer from real-world Czech data
Pavel Hradilek, Olga Zapletalova, Petra Hanulikova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 27, 2025
Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial
Peter A Calabresi, Gavin Giovannoni, Hans-Peter Hartung, et al.
Bioorganic Chemistry
|
January 9, 2021
Tacrine - Benzothiazoles: Novel class of potential multitarget anti-Alzheimeŕs drugs dealing with cholinergic, amyloid and mitochondrial systems
Eugenie Nepovimova, Lucie Svobodova, Rafael Dolezal, et al.
European Journal of Medicinal Chemistry
|
March 10, 2019
Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease
Katarina Chalupova, Jan Korabecny, Manuela Bartolini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 4, 2021
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study
Amit Bar-Or, Heinz Wiendl, Xavier Montalban, et al.
Page
of 11